Logo image of GTLB

GITLAB INC-CL A (GTLB) Stock Fundamental Analysis

NASDAQ:GTLB - Nasdaq - US37637K1088 - Common Stock - Currency: USD

56.38  -1.87 (-3.21%)

After market: 56.38 0 (0%)

Fundamental Rating

5

Taking everything into account, GTLB scores 5 out of 10 in our fundamental rating. GTLB was compared to 283 industry peers in the Software industry. GTLB has a great financial health rating, but its profitability evaluates not so good. GTLB is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GTLB had positive earnings in the past year.
In the past year GTLB has reported a negative cash flow from operations.
GTLB had negative earnings in each of the past 5 years.
In the past 5 years GTLB reported 4 times negative operating cash flow.
GTLB Yearly Net Income VS EBIT VS OCF VS FCFGTLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

The Return On Assets of GTLB (-0.10%) is better than 62.19% of its industry peers.
Looking at the Return On Equity, with a value of -0.17%, GTLB is in the better half of the industry, outperforming 63.25% of the companies in the same industry.
Industry RankSector Rank
ROA -0.1%
ROE -0.17%
ROIC N/A
ROA(3y)-15.71%
ROA(5y)-22.87%
ROE(3y)-32.9%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
GTLB Yearly ROA, ROE, ROICGTLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

GTLB has a better Gross Margin (88.79%) than 94.35% of its industry peers.
GTLB's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for GTLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.05%
GTLB Yearly Profit, Operating, Gross MarginsGTLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

GTLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GTLB has more shares outstanding
The number of shares outstanding for GTLB has been increased compared to 5 years ago.
There is no outstanding debt for GTLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GTLB Yearly Shares OutstandingGTLB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
GTLB Yearly Total Debt VS Total AssetsGTLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 8.69 indicates that GTLB is not in any danger for bankruptcy at the moment.
GTLB's Altman-Z score of 8.69 is amongst the best of the industry. GTLB outperforms 80.92% of its industry peers.
GTLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.69
ROIC/WACCN/A
WACC13.94%
GTLB Yearly LT Debt VS Equity VS FCFGTLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

GTLB has a Current Ratio of 2.47. This indicates that GTLB is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.47, GTLB is doing good in the industry, outperforming 68.55% of the companies in the same industry.
GTLB has a Quick Ratio of 2.47. This indicates that GTLB is financially healthy and has no problem in meeting its short term obligations.
GTLB has a better Quick ratio (2.47) than 69.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
GTLB Yearly Current Assets VS Current LiabilitesGTLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 289.47% over the past year.
Looking at the last year, GTLB shows a very strong growth in Revenue. The Revenue has grown by 30.92%.
GTLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.37% yearly.
EPS 1Y (TTM)289.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)30.92%
Revenue growth 3Y44.3%
Revenue growth 5Y56.37%
Sales Q2Q%29.09%

3.2 Future

The Earnings Per Share is expected to grow by 19.51% on average over the next years. This is quite good.
Based on estimates for the next years, GTLB will show a very strong growth in Revenue. The Revenue will grow by 20.88% on average per year.
EPS Next Y9.26%
EPS Next 2Y18.46%
EPS Next 3Y13.47%
EPS Next 5Y19.51%
Revenue Next Year25.11%
Revenue Next 2Y23.82%
Revenue Next 3Y24.05%
Revenue Next 5Y20.88%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GTLB Yearly Revenue VS EstimatesGTLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
GTLB Yearly EPS VS EstimatesGTLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 -1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 76.19, GTLB can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as GTLB.
When comparing the Price/Earnings ratio of GTLB to the average of the S&P500 Index (29.35), we can say GTLB is valued expensively.
The Price/Forward Earnings ratio is 69.73, which means the current valuation is very expensive for GTLB.
GTLB's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. GTLB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 76.19
Fwd PE 69.73
GTLB Price Earnings VS Forward Price EarningsGTLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GTLB Per share dataGTLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GTLB's earnings are expected to grow with 13.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.23
PEG (5Y)N/A
EPS Next 2Y18.46%
EPS Next 3Y13.47%

More info and screens

0

5. Dividend

5.1 Amount

GTLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GITLAB INC-CL A

NASDAQ:GTLB (3/7/2025, 8:00:01 PM)

After market: 56.38 0 (0%)

56.38

-1.87 (-3.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)06-03 2025-06-03/amc
Inst Owners84.64%
Inst Owner Change3.33%
Ins Owners3.31%
Ins Owner Change3.47%
Market Cap9.24B
Analysts82.29
Price Target82.83 (46.91%)
Short Float %7.72%
Short Ratio3.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.93%
Min EPS beat(2)42.63%
Max EPS beat(2)45.23%
EPS beat(4)4
Avg EPS beat(4)78.32%
Min EPS beat(4)42.63%
Max EPS beat(4)177.48%
EPS beat(8)8
Avg EPS beat(8)214.07%
EPS beat(12)12
Avg EPS beat(12)158.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.42%
Min Revenue beat(2)0.56%
Max Revenue beat(2)2.27%
Revenue beat(4)3
Avg Revenue beat(4)1.01%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)2.27%
Revenue beat(8)7
Avg Revenue beat(8)2.53%
Revenue beat(12)11
Avg Revenue beat(12)3.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.46%
PT rev (3m)20.19%
EPS NQ rev (1m)0.6%
EPS NQ rev (3m)38.46%
EPS NY rev (1m)0.2%
EPS NY rev (3m)22.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)1.9%
Valuation
Industry RankSector Rank
PE 76.19
Fwd PE 69.73
P/S 12.17
P/FCF N/A
P/OCF N/A
P/B 11.85
P/tB 12.39
EV/EBITDA N/A
EPS(TTM)0.74
EY1.31%
EPS(NY)0.81
Fwd EY1.43%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS4.63
BVpS4.76
TBVpS4.55
PEG (NY)8.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.79%
FCFM N/A
ROA(3y)-15.71%
ROA(5y)-22.87%
ROE(3y)-32.9%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.25%
GM growth 5Y0.05%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.27%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 8.69
F-Score4
WACC13.94%
ROIC/WACCN/A
Cap/Depr(3y)55.77%
Cap/Depr(5y)176.52%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)289.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y9.26%
EPS Next 2Y18.46%
EPS Next 3Y13.47%
EPS Next 5Y19.51%
Revenue 1Y (TTM)30.92%
Revenue growth 3Y44.3%
Revenue growth 5Y56.37%
Sales Q2Q%29.09%
Revenue Next Year25.11%
Revenue Next 2Y23.82%
Revenue Next 3Y24.05%
Revenue Next 5Y20.88%
EBIT growth 1Y24.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.32%
EBIT Next 3Y38.32%
EBIT Next 5Y40.27%
FCF growth 1Y-302.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-282.57%
OCF growth 3YN/A
OCF growth 5YN/A